Early stroke and systemic embolism rates in patients following cardioversion for atrial fibrillation (A-fib) are low and comparable between those receiving warfarin or the novel oral anticoagulant ...
But the current study, from Dr Gaetano M De Ferrari (University of Pavia, Italy) and colleagues, suggests that there can be a role for cardioversion in some populations, in this case patients with ...
Introduction: There is insufficient evidence on the efficacy and safety of pharmacological cardioversion of recent‑onset atrial fibrillation (AF) in elderly patients. Antazoline has been shown to be ...
A team of Ochsner Health cardiologists recently published an article in the Journal of the American Medical Association (JAMA) Cardiology comparing two treatment strategies for patients with atrial ...
PHILADELPHIA -- For atrial fibrillation (Afib) patients with obesity, a second set of defibrillation pads for dual direct current cardioversion safely improved the success of the procedure, a ...
LISBON, Portugal—Patients presenting to the emergency department (ED) with new, symptomatic A-fib do not necessarily need to undergo immediate cardioversion, as is now common practice, the RACE 7 ...
The 2006 American College of Cardiology/American Heart Association/European Society of Cardiology (ACC/AHA/ESC) Practice Guidelines for the Management of Atrial Fibrillation state that various benign ...
The drug-shock strategy was more effective for patients experiencing atrial fibrillation for the first time and for patients younger than 70 years, the researchers said. Both the anti-arrhythmia drug ...
Patients with atrial fibrillation (AF) who need anticoagulation before undergoing electrical correction of their abnormal heartbeat (cardioversion) may benefit from treatment with edoxoban - a ...
Cardioversion can improve heart function, reduce the risk of embolism and relieve symptoms in patients with atrial fibrillation. Despite anticoagulation therapy, thromboembolic complications can still ...
Patients presenting to the emergency department with recent-onset atrial fibrillation (AF) do not benefit more from early cardioversion compared with a wait-and-see approach in achieving a return to ...